Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nomination of Kashyap Patel, of Nevada, to be Director of the Federal Bureau of Investigation, Department of Justice.

Name: Business meeting to consider S.331, to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and the nomination of Kashyap Patel, of Nevada, to be Director of the Federal Bureau of Investigation, Department of Justice.
Start: 2025-02-13T14:00:00Z
End: 2025-02-13T14:00:00Z

Scheduled · Feb 13, 2025, 2:00 PM

Type: Meeting
Committees: Senate Judiciary
Room: 216
Building: Dirksen Senate Office Building

Related bills

No related bill details are available for this meeting yet.

Witnesses

No witnesses are listed for this meeting.